Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Tilray Brands, Inc.NASDAQ: TLRY

Gross Margin · Q3 FY2026 · quarter ended Feb 2026

Gross margin narrows to 26.6%

Gross margin was 26.6% in Q3 FY2026, down 1.4 pp from a year earlier. On a trailing-twelve-month basis it was 27.7%, down 3.2 pp year over year. Over 3 fiscal years it widened by 10.7 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
26.6%+0.1 pp QoQ
Last fiscal yearMay 2025
29.3%+1.0 pp YoY
LTMFeb 2026
27.7%-3.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.4 pp——
1 year+1.0 pp——
3 years+10.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
29.3%
Year-over-year change
+1.0pp

Gross Margin vs competitors

How TLRY compares with its peers on the latest reported figures

  • TLRY's LTM Feb 2026 gross margin of 27.7% is the 2nd highest of the 3 companies compared; the peer median is 41.9%.
  • Its year-over-year change of -3.2 pp is the lowest of 3, against a peer median of +1.3 pp.
  • Over three fiscal years its change of +10.7 pp compares with a peer median of +3.1 pp.
TLRY Competitors Peer median
Gross Margin for TLRY and competitors
Company Period LTM level YoY 3-year change
ACBAurora Cannabis Inc.LTM Mar 202656.6% +2.0 pp-1.4 pp
TLRYTilray Brands, Inc.LTM Feb 202627.7% -3.2 pp+10.7 pp
SNDLSNDL Inc.LTM Mar 202627.2% +0.6 pp+7.6 pp
GLASGlass House Brands Inc—— ——
Peer median (excluding TLRY) 41.9%+1.3 pp+3.1 pp

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue619.67M792.12M844.72M1.07B1.13B
Cost of Revenue470.9M644.86M646.77M770.66M796.88M
Gross Profit148.77M147.26M197.95M304.33M330.11M
Gross Margin24.0%18.6%23.4%28.3%29.3%
Research & Development1M1.91M918.64K865.23K389.7K
Selling, General & Admin188.03M233.38M311.13M341.63M356.06M
Operating Expenses308.4M916.72M2.04B542.43M3.46B
Depreciation & Amortization81.92M194.88M175.31M172.93M183.17M
EBITDA(297.41M)(310.61M)(1.72B)(99.25M)(2.92B)
EBITDA Margin-48.0%-39.2%-203.1%-9.2%-259.0%
Operating Income(159.63M)(769.46M)(1.84B)(238.1M)(3.13B)
Operating Margin-25.8%-97.1%-218.4%-22.1%-277.9%
Interest Income3.53M14.79M44.48M17.48M15.61M
Interest Expense37.32M50.02M62.79M67.13M56.71M
Other Income / Expenses(257.02M)213.96M(108.43M)(101.2M)(26.99M)
Income Before Tax(416.65M)(555.51M)(1.95B)(339.31M)(3.16B)
Pre-Tax Margin-67.2%-70.1%-231.2%-31.6%-280.3%
Income Tax Expense(10.84M)(8.25M)(9.67M)(36.27M)(166.06M)
Net Income(443.75M)(601.05M)(1.96B)(333.8M)(3B)
Net Margin-71.6%-75.9%-231.6%-31.1%-266.3%
EPS (Basic)(13.61)(9.94)(31.70)(4.50)(33.80)
EPS (Diluted)(13.61)(9.94)(31.70)(4.50)(33.80)
Weighted Avg Shares26.95M48.12M61.8M74.26M89.03M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M89.03M

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.